Search results
Covid vaccines may have helped fuel rise in excess deaths
The Telegraph via Yahoo News· 9 hours agoResearchers said the figure included deaths from Covid-19, but also the “indirect effects of the...
ESHG: Neoantigen Vaccine Helps Prevent Cancer in Lynch Syndrome Patients
GenomeWeb News· 7 hours agoA neoantigen vaccine was able to prevent cancer in a subset of Lynch syndrome patients who mounted a T-cell response to one of the neoantigens, increasing their chance of ...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 1 day agoModerna and Merck released more positive three-year data Monday on their experimental vaccine, given...
Vaccines Fast Facts – KION546
KION 46 Salinas· 6 days agoFor more than 100 years, there has been public discord regardingvaccines based on issues like individual rights, religious freedoms, distrust of...
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
Investor's Business Daily· 4 days agoThe shot was also 68.4% effective against acute respiratory disease. William Blair analyst Myles...
The COVID-19 Vaccines Shouldn't Have Been Free
Reason.com via Yahoo News· 5 days ago(Unlike standard, non-COVID vaccines, people are also not allowed to sue the government for compensation for the vaccine injuries.) If pharmaceutical...
Doctor hails launch of cancer vaccine as a 'new age' in fight against disease
Daily Express· 4 days agoA GP of 30 years has hailed the trial of an innovative cancer vaccine as a “significant...
Thousands of cancer patients to trial personalised vaccines
BBC via Yahoo News· 5 days agoThe study is not due to be completed until 2027. One hope is that the vaccines will produce fewer ...
Cancer vaccine hailed as 'game-changer'
Newsweek· 4 days agoCancer patients in the U.K. are about to get personalized cancervaccines as part of a new trial. Unlike vaccines for diseases like the flu or COVID-19,...
FDA approves Moderna’s mRNA RSV vaccine
The Hill via Yahoo News· 4 days agoThe Food and Drug Administration (FDA) has approved Moderna’s RSV mRNA vaccine for adults older than 60 years. The approval makes RSV the second disease...
